Skip to content

Effect of Rasnadi Guggulu , Rasnadashamooladi Kwatha and Griva Vasti in Cervical Spondylosis

Clinical Evaluation of Efficacy of ââ?¬Å?Rasnadi Gugguluââ?¬? , ââ?¬Å?Rasnadashamooladi Kwathaââ?¬? and ââ?¬Å?Griva Vastiââ?¬? in the Management of Griva-Sandhigata Vata (Cervical Spondylosis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014141
Enrollment
30
Registered
2018-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cervical Spondylosis

Interventions

Intervention1: Rasnadi Guggulu and Rasnadashamooladi Kwatha : "Rasnadi Gugguluââ?¬? 2tab. (each tab. of 500 mg) three times in a day with lukewarm water and ââ?¬Å?Rasnadashamooladi Kwathaââ?¬? 30

Sponsors

National Institute of Ayurveda
Lead Sponsor
Prof Chandra Bhanu Sharma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to signature the consent form for the clinical trial. 2. Patients of either sex. 3. Patients above 20 years and less than 70 years. 4. Clinical symptoms of ââ?¬Ë?Griva-Sandhigata Vataââ?¬• (Cervical Spondylosis) with or without radiological changes.

Exclusion criteria

Exclusion criteria: 1. Stenosis of spinal cord 2. Contraindication and allergy to any drug in Rasnadi Guggulu, Rasnadashamooladi Kwatha or Dashamooladi Taila used for Griva Vasti. 3. Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy. 4. Myofacial pain 5. Patients suffering from any infectious disease (like tuberculosis), metabolic disease (like diabetes mellitus and hypothyroidism), chronicdisease (like rheumatoid arthritis, SLE, ankylosing spondylitis). 6. Pregnant and lactating mothers.

Design outcomes

Primary

MeasureTime frame
reduction of cervical painTimepoint: 1 month

Secondary

MeasureTime frame
improvement of quality of lifeTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Kartar Bansal

National Institute of Ayurveda, Jorawar Singh Gate

sharmacbayu5@gmail.com8209984905

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026